🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Juneko E. Grilley‐Olson

ORCID: 0000-0002-1896-7020
MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Data from A Randomized Multi-institutional Phase II Trial of Everolimus as Adjuvant Therapy in Patients with Locally Advanced Squamous Cell Cancer of the Head and Neck

(2023)10.1158/1078-0432.c.6532910.v1
Top 100%
0DataRank
Top 100%0 citations

D. Neil Hayes, Theodore Karrison, Olivier Harismendy, José M. Flores, Tara Moore‐Medlin +17 more

Papers

Driven by 4 papers — median percentile 0. Top paper: “Larotrectinib Treatment for Patients With TRK Fusion-Positive Salivary Gland Cancers”.

Larotrectinib Treatment for Patients With TRK Fusion-Positive Salivary Gland Cancers

The Oncologist(2022)10.1093/oncolo/oyac080
N/A
1.7DataRank · unranked
49 citations

Christina S. Baik, Jessica R. Bauman, Jill Gilbert, Marcia S. Brose, Juneko E. Grilley‐Olson +13 more

A multicenter phase II study of cabozantinib + nivolumab for patients (pts) with advanced angiosarcoma (AS) previously treated with a taxane (Alliance A091902).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.11503
N/A
0DataRank · unranked
35 citations

Jacob B. Allred, Scott M. Schuetze, Elizabeth J. Davis, Michael J. Wagner, Andrew Poklepovic +10 more

Data from A Randomized Multi-institutional Phase II Trial of Everolimus as Adjuvant Therapy in Patients with Locally Advanced Squamous Cell Cancer of the Head and Neck

(2023)10.1158/1078-0432.c.6532910.v1
Top 100%
0DataRank
Top 100%0 citations

D. Neil Hayes, Theodore Karrison, Olivier Harismendy, José M. Flores, Tara Moore‐Medlin +17 more

Incidence and Presenting Characteristics of Angiosarcoma in the US, 2001-2020

JAMA Network Open(2024)10.1001/jamanetworkopen.2024.6235
N/A
0DataRank · unranked
43 citations

Vinod Ravi, Stephanie K. Schaub, E.Y. Kim, Jeremy Sharib, Harveshp Mogal +11 more